SFS
ENTA icon

Sowell Financial Services’s Enanta Pharmaceuticals ENTA Stock Holding History

Sowell Financial Services’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-40
Closed -$2K – 2728
2020
Q3 		$2K Sell
40
-72
-64% -$3.49K ﹤0.01% 2210
2020
Q2 		$6K Sell
112
-412
-79% -$21.3K ﹤0.01% 1835
2020
Q1 		$27K Sell
524
-243
-32% -$13K ﹤0.01% 1277
2019
Q4 		$47K Buy
+767
New +$47.5K ﹤0.01% 1165

Other funds holding ENTA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Sowell Financial Services's ENTA Position: Q4 2020 in Review

Sowell Financial Services sold out of Enanta Pharmaceuticals (ENTA) in Q4 2020, closing a stake of 40 shares — an estimated $2K sold.

Sowell Financial Services first reported a position in ENTA in Q4 2019 and held it in 4 quarters. The position peaked at $47K in Q4 2019. 151 funds tracked by Wall St. Rank hold ENTA as of Q4 2020.

  • Sowell Financial Services reported no remaining Enanta Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Sowell Financial Services sold 40 Enanta Pharmaceuticals shares in Q4 2020, an estimated $2K.
  • Sowell Financial Services first reported a position in Enanta Pharmaceuticals in Q4 2019 and held it in 4 quarters.
  • Sowell Financial Services's Enanta Pharmaceuticals position peaked at $47K in Q4 2019.
  • 151 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q4 2020.

Based on Sowell Financial Services's 13F filing for Q4 2020, filed 13 Jan 2021.